DK3710437T3 - Enantiomerseparation af racemisk nicotin ved tilsætning af en o,o'-disubstitueret vinsyreenantiomer med lav optisk renhed - Google Patents

Enantiomerseparation af racemisk nicotin ved tilsætning af en o,o'-disubstitueret vinsyreenantiomer med lav optisk renhed Download PDF

Info

Publication number
DK3710437T3
DK3710437T3 DK18816112.9T DK18816112T DK3710437T3 DK 3710437 T3 DK3710437 T3 DK 3710437T3 DK 18816112 T DK18816112 T DK 18816112T DK 3710437 T3 DK3710437 T3 DK 3710437T3
Authority
DK
Denmark
Prior art keywords
enantiomer
disustituted
addition
optical purity
low optical
Prior art date
Application number
DK18816112.9T
Other languages
English (en)
Inventor
Beat Weber
Ben Pan
Original Assignee
Siegfried Ag
Contraf Nicotex Tobacco Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ag, Contraf Nicotex Tobacco Gmbh filed Critical Siegfried Ag
Application granted granted Critical
Publication of DK3710437T3 publication Critical patent/DK3710437T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Addiction (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK18816112.9T 2017-12-22 2018-12-18 Enantiomerseparation af racemisk nicotin ved tilsætning af en o,o'-disubstitueret vinsyreenantiomer med lav optisk renhed DK3710437T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17210181 2017-12-22
PCT/EP2018/085444 WO2019121649A1 (en) 2017-12-22 2018-12-18 Enantiomeric separation of racemic nicotine by addition of an o,o'-disubstituted tartaric acid enantiomer

Publications (1)

Publication Number Publication Date
DK3710437T3 true DK3710437T3 (da) 2023-02-20

Family

ID=60782088

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18816112.9T DK3710437T3 (da) 2017-12-22 2018-12-18 Enantiomerseparation af racemisk nicotin ved tilsætning af en o,o'-disubstitueret vinsyreenantiomer med lav optisk renhed

Country Status (28)

Country Link
US (1) US11279685B2 (da)
EP (1) EP3710437B1 (da)
JP (1) JP7030208B2 (da)
KR (1) KR20200103730A (da)
CN (1) CN111527077B (da)
AU (1) AU2018391657B2 (da)
BR (1) BR112020012458A2 (da)
CA (1) CA3085208C (da)
CL (1) CL2020001656A1 (da)
CY (1) CY1125900T1 (da)
DK (1) DK3710437T3 (da)
ES (1) ES2940319T3 (da)
FI (1) FI3710437T3 (da)
HR (1) HRP20230119T1 (da)
HU (1) HUE061702T2 (da)
IL (1) IL275585B2 (da)
LT (1) LT3710437T (da)
MY (1) MY193072A (da)
NZ (1) NZ765535A (da)
PE (1) PE20211392A1 (da)
PL (1) PL3710437T3 (da)
PT (1) PT3710437T (da)
RS (1) RS64017B1 (da)
RU (1) RU2753492C1 (da)
SG (1) SG11202005641XA (da)
SI (1) SI3710437T1 (da)
WO (1) WO2019121649A1 (da)
ZA (1) ZA202003683B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7085641B2 (ja) 2017-12-22 2022-06-16 ジークフリート アクチェンゲゼルシャフト アルコラート塩基の存在下でのニコチン酸エチルとｎ－ビニルピロリドンとの反応によるラセミ体ニコチンの調製方法
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance
CN111187250B (zh) * 2020-01-08 2023-04-07 深圳黑尔格科技有限公司 一种拆分式制备光学活性尼古丁的方法
CN114644614B (zh) * 2021-04-21 2023-03-28 黄冈中有生物科技有限公司 一种左旋烟碱的制备方法
CN115246815A (zh) * 2021-04-27 2022-10-28 黄冈中有生物科技有限公司 一种烟碱的制备方法
CN115260088A (zh) * 2021-04-30 2022-11-01 武汉中有药业有限公司 烟碱及其中间体的制备方法
CN113416180A (zh) * 2021-08-09 2021-09-21 东莞市鸿馥生物科技有限公司 一种(s)-1-甲基-2-(3-吡啶基)吡咯烷的拆分方法
CN114249711A (zh) * 2022-03-02 2022-03-29 北京邦克凯姆医药科技有限公司 一种拆分制备尼古丁的方法
CN114671852A (zh) * 2022-04-24 2022-06-28 仙居两山生物科技有限公司 一种高纯度左旋烟碱医药中间体的制备方法
CN117362270A (zh) * 2022-07-01 2024-01-09 湖北和诺生物工程股份有限公司 一种消旋尼古丁的制备方法及左旋尼古丁的拆分方法
CN115093394B (zh) * 2022-07-20 2024-10-18 北京世桥生物制药有限公司 S-(-)-尼古丁(-)-二苯甲酰-l-酒石酸盐晶型、制备方法及应用
CN115286615A (zh) * 2022-09-01 2022-11-04 深圳市真味生物科技有限公司 一种消旋尼古丁的制备方法
CN117105907A (zh) * 2023-08-15 2023-11-24 湖北和诺生物工程股份有限公司 一种外消旋烟碱的拆分方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003342259A (ja) 2001-12-21 2003-12-03 Toray Ind Inc 光学活性シスピペリジン誘導体の製造法
JP2006335639A (ja) 2003-01-23 2006-12-14 Nagase & Co Ltd 光学活性なフルルビプロフェンの製造方法
CN102617547B (zh) 2011-01-27 2016-02-10 上海特化医药科技有限公司 一种制备消旋尼古丁的方法
US8378111B2 (en) * 2011-02-02 2013-02-19 Divi's Laboratories, Ltd. Process for the resolution of (R,S)-nicotine
US8367837B2 (en) 2011-02-14 2013-02-05 Divi's Laboratories, Ltd. Process for the preparation of (R,S)-nicotine
WO2016065209A2 (en) 2014-10-22 2016-04-28 Next Generation Labs, LLC Process for the preparation of (r,s)-nicotine
US9809567B2 (en) * 2014-12-09 2017-11-07 Njoy, Llc Synthesis and resolution of nicotine
EP3397081A4 (en) 2015-12-30 2019-08-28 Next Generation Labs, LLC NICOTRENATE THERAPY PRODUCTS WITH SYNTHETIC NICOTINE
EP3400219B1 (en) 2016-01-08 2020-03-25 Council of Scientific and Industrial Research A process for the preparation of nicotine
JP7085641B2 (ja) 2017-12-22 2022-06-16 ジークフリート アクチェンゲゼルシャフト アルコラート塩基の存在下でのニコチン酸エチルとｎ－ビニルピロリドンとの反応によるラセミ体ニコチンの調製方法

Also Published As

Publication number Publication date
CA3085208C (en) 2023-05-23
CN111527077B (zh) 2023-03-10
WO2019121649A1 (en) 2019-06-27
AU2018391657A1 (en) 2020-07-09
IL275585B2 (en) 2023-09-01
SG11202005641XA (en) 2020-07-29
JP7030208B2 (ja) 2022-03-04
US11279685B2 (en) 2022-03-22
AU2018391657B2 (en) 2022-03-10
CL2020001656A1 (es) 2020-11-13
PT3710437T (pt) 2023-03-17
JP2021515029A (ja) 2021-06-17
NZ765535A (en) 2024-03-22
BR112020012458A2 (pt) 2020-11-24
IL275585A (en) 2020-08-31
FI3710437T3 (fi) 2023-03-23
EP3710437A1 (en) 2020-09-23
SI3710437T1 (sl) 2023-04-28
CY1125900T1 (el) 2024-09-20
CN111527077A (zh) 2020-08-11
KR20200103730A (ko) 2020-09-02
RU2753492C1 (ru) 2021-08-17
CA3085208A1 (en) 2019-06-27
PL3710437T3 (pl) 2023-04-11
PE20211392A1 (es) 2021-07-27
HUE061702T2 (hu) 2023-08-28
ZA202003683B (en) 2023-01-25
IL275585B1 (en) 2023-05-01
MY193072A (en) 2022-09-26
ES2940319T3 (es) 2023-05-05
LT3710437T (lt) 2023-04-25
HRP20230119T1 (hr) 2023-03-31
EP3710437B1 (en) 2022-12-14
RS64017B1 (sr) 2023-03-31
US20200331883A1 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
SI3710437T1 (sl) Enantiomerno ločevanje racemnega nikotina z dodajanjem enantiomera o,o'-distribuirane vinske kisline z nizko optično čistostjo
EP3431075A4 (en) EDARAVONDARREICHUNGSFORM
DK2968218T3 (da) Kombination til behandling af parkinsons sygdom
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
EP3589623C0 (en) PREPARATION OF DICARBOXYLIC ACID FROM 2,5-FURAN
EP3349587A4 (en) PROCESS FOR FUNGICIDE COMPOUND
IL271399A (en) Methods for the preparation of heterocyclic 3,1-benzodioxole compounds
DK2987791T3 (da) 3-(4-(Benzyloxy)phenyl)hex-4-insyre-derivat, egnet til forebyggelse og behandling af metaboliske sygdomme
DK3054927T3 (da) Formuleringer af (s)-3-(4-((4-morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidin-2,6-dion
EP2900085A4 (en) PROCESS FOR PRODUCING NATURAL KOKUMI TASTE
DK3390407T3 (da) Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
EP3438048A4 (en) METHOD FOR PRODUCING BINAR-FREE, COAL-BASED, BRIKETTED ACTIVE CARBON
DK3279202T3 (da) Krystal af 3,5-disubstitueret benzenalkynylforbindelse
EP3632441A4 (en) METHOD FOR ESTABLISHING AN OPTICALLY ACTIVE CONNECTION
WO2014192030A3 (en) An improved process for preparation of dabigatran etexilate and pharmaceutically acceptable acid addition salts thereof
DK3807260T3 (da) Oprensning af nikotin
DK3784649T3 (da) Fremgangsmåde til syntese af (s)-3-amino-4-(difluormethylenyl)cyclopent-1-en-1-carboxylsyre
DK3722284T3 (da) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4,5]-decan-derivater
DK3458467T3 (da) Fremgangsmåde til 6,7-alfa-epoxidering af steroid-4,6-diener
DK3624795T3 (da) Kondenserede, heteroaromatiske anilinforbindelser til behandling af hudforstyrrelser
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
ITUA20161541A1 (it) Gruppo assale con cuscinetti dell'assale esterni
WO2015128875A3 (en) A process for preparation of dabigatran etexilate mesylate and intermediates thereof
DK3619199T3 (da) Fremstilling af 2-([1,2,3]triazol-2-yl)-benzoesyrederivater
EP3533856A4 (en) METHOD FOR PRODUCING HEXADECAHYDROPYRENE